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Abstract
Voltage-gated sodium channels are pore-forming transmembrane proteins that selectively allow
sodium ions to flow across the plasmamembrane according to the electro-chemical gradient thus
mediating the rising phase of action potentials in excitable cells and playing key roles in physiolog-
ical processes such as neurotransmission, skeletalmuscle contraction, heart rhythm, and pain sen-
sation. Genetic variations in the nine human genes encoding these channels are known to cause a
large range of diseases affecting the nervous and cardiac systems. Understanding the molecular
effect of genetic variations is critical for elucidating the pathologic mechanisms of known varia-
tions and in predicting the effect of newly discovered ones. To this end, we have created a Web-
based tool, the Ion Channels Variants Portal, which compiles all variants characterized function-
ally in the human sodium channel genes. This portal describes 672 variants each associated with
at least one molecular or clinical phenotypic impact, for a total of 4,658 observations extracted
from 264 different research articles. These data were captured as structured annotations using
standardized vocabularies and ontologies, such as the Gene Ontology and the Ion Channel Elec-
troPhysiology Ontology. All these data are available to the scientific community via neXtProt at
https://www.nextprot.org/portals/navmut.
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1 INTRODUCTION
Ion channels are integral membrane proteins that allow ions to flow
across membranes in all living cells, playing an important role in key
physiological processes such as neurotransmission, muscle contrac-
tion, learning and memory, secretion, cell proliferation, regulation of
blood pressure, fertilization, and cell death. In humans, 344 genes
encode the pore-forming subunits of ion channels. Mutations in more
than 126 ion channel as well as in several ion channel-interacting
protein genes have been reported to cause diseases, known as chan-
nelopathies (Ashcroft, 2006). The voltage-gated sodium channel group
comprises nine members in mammals: SCN1A–SCN5A, corresponding
to Nav1.1 to Nav1.5, and SCN8A–SCN11A, corresponding to Nav1.6
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to Nav1.9 (Table 1). SCN7A corresponding to Nax is not included in
this group as it is not voltage sensitive. These channels are proteins of
about 2,000 amino acids that are composed of four domains (DI–DIV),
each consisting of six transmembrane helices (S1–S6) and connected
to each other by the L1, L2, and L3 linkers (Figure 1). They interact
with other proteins that modulate channel gating properties as well as
channel trafficking and subcellular localization. Regions known to be
involved in the gating properties and the protein–protein interactions
are listed in Table 2 (Ahern, Payandeh, Bosmans, & Chanda, 2016).
Disruption of any aspect of the channel function can cause a wide
spectrum of diseases. Depending on their tissue expression, defects
in their function cause disorders such as epilepsy and seizures, paral-
ysis, myotonia, pain disorders, autism, cognitive impairments, as well
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TABLE 1 Diseases associated withmutations in voltage-gated sodium channels
Gene Protein OMIM ID neXtProt ID
Major
Expression
HumanDisorders due toMutations in Voltage-Gated Sodium
Channels
SCN1A Nav1.1 182389 NX_P35498 CNS, PNS Generalized Epilepsy with Febrile Seizures Plus, Dravet
Syndrome, Febrile Seizure, Familial HemiplegicMigraine,
Acute Encephalopathy, JuvenileMyoclonic Epilepsy
Intractable without Status Epilepticus
SCN2A Nav1.2 182390 NX_Q99250 CNS, PNS Epileptic encephalopathy, Dravet Syndrome, Autism, Intellectual
Disability, Generalized Epilepsy with Febrile Seizures Plus
SCN3A Nav1.3 182391 NX_Q9NY46 CNS, PNS Partial Epilepsy, Generalized Epilepsy with Febrile Seizures Plus
SCN4A Nav1.4 603967 NX_P35499 Skeletal muscle Hypokalemic Periodic Paralysis, Hyperkalemic Periodic
Paralysis, Paramyotonia Congenita, Myotonic Disorder
SCN5A Nav1.5 600163 NX_Q14524 Cardiacmuscle Brugada Syndrome, LongQT Syndrome, Ventricular Arrhythmia,
Sudden Infant Death Syndrome, Dilated Cardiomyopathy, Sick
Sinus Syndrome
SCN8A Nav1.6 600702 NX_Q9UQD0 CNS, PNS Epileptic encephalopathy,Migrating Partial Seizures in Infancy,
Intellectual Disability
SCN9A Nav1.7 603415 NX_Q15858 PNS Primary Erythromelalgia, Pain Insensitivity, Paroxysmal Extreme
Pain Disorder, Small Fiber Neuropathy
SCN10A Nav1.8 604427 NX_Q9Y5Y9 PNS Peripheral Neuropathy, Primary Erythromelalgia, Small Fiber
Neuropathy
SCN11A Nav1.9 604385 NX_Q9UI33 PNS Small Fiber Neuropathy, Episodic Pain Syndrome Familial 3,
NeuropathyHereditary Sensory and Autonomic Type VII
Note: CNS, central nervous system; PNS, peripheral nervous system.
F IGURE 1 Topology of voltage-gated sodium channels
as many cardiac arrhythmic syndromes (Table 1). Several genetic vari-
ations are known to affect voltage-gated sodium channels leading to a
defect in their cellular or biophysical properties, and consequently to
the development of diseases. Knowledge on the effect of these muta-
tions is spread across the scientific literature. Consolidating these data
in a single platformwill help scientists and clinicians to have a source of
validated information for general reference, aswell as to help in clinical
applications such as diagnosis, genetic, and therapeutic counseling.
Undeniably, there is a need for an integrated and comprehensive
resource that describes the current state of knowledge of the impact
of mutations at the molecular and/or cellular levels, in a format com-
patible with computational analysis. Some clinically relevant variants
are reported in several public databases, such as ClinVar (https://www.
ncbi.nlm.nih.gov/clinvar/) and OMIM (http://omim.org/). These
resources mainly focus on the clinical aspects of variants. Channel-
pedia (http://channelpedia.epfl.ch/), developed by the Blue Brain
Project, was created with the intention of capturing all information
related to ion channels. However, its content is specifically focused on
data required for biophysical modeling and has limited information
on the biological roles and molecular function of individual protein
residues. Another pertinent resource is IUPHAR-DB (http://www.
guidetopharmacology.org/), which is developed by the International
Union of Basic and Clinical Pharmacology. This database includes
genetic, proteomic, pharmacological, some functional, and biophysical
characteristics but lacks detailed information on the functional impact
of sequence variations. Finally, there are also several locus- or disease-
specific resources that exist suchashttp://www.molgen.vib-ua.be/scn1
amutations/; http://www.gzneurosci.com/scn1adatabase/; https://
gene.sfari.org/GeneDetail/SCN2A; http://triad.fsm.it/cardmoc/ (last
modified in 2010). However, none of the above resources is provided
in a format that is amenable to computational analyses and many of
them have not been updated for years.
In this article, we describe the generation of the neXtProt
Ion Channels Variants Portal, available at https://www.nextprot.
org/portals/navmut, a corpus of data of voltage-gated sodium chan-
nel mutations consisting of over 4,600 observations at the molecular
and/or cellular level on 672 variants. The unique features of the portal
are as follows:wecapturedbothnaturalmutations found inpatients, as
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TABLE 2 Regions related to sodium channel’s function
Channel Function Interaction Partners Region
Voltage sensing domain S1, S2, S3, and S4
Filter pore S5-S6 loop
Inactivation gate L3
Site of inactivation gate S4-S5 loop in DIII
Beta partners N-term and C-term
Kinases
PKC L1 and L3
PKA L1
CSNK2A2 L2
GSK3B C-term
Trafficking partners
Ankyrin L2
Calmodulin C-term
NEDD4L C-term
FGF C-term
well as artificialmutations designed to study specific aspects of protein
function in vitro and/or in vivo; we annotated the phenotypic impact
of variants for all nine members of the voltage-gated sodium channel
family; all data are represented using standardized vocabularies; and
last but not least, each statement is reviewed by an expert curator and
goes through a thorough quality control process.
2 MATERIALS AND METHODS
2.1 Selection of data for curation
The Ion Channels Variants Portal presents data on the molecular, cel-
lular, and organ-level phenotypes caused by genetic variations in the
nine human voltage-gated sodium channels. Only variations that affect
the coding sequence and give a defined mutated product have been
considered, excluding intronic or splice site variations. This informa-
tionwasmanually extracted from research articles indexed in PubMed
and captured using an in-house developed biocuration software plat-
form, the BioEditor. This tool allows the capture of structured annota-
tions using standardized vocabularies. The experimental evidence sup-
porting each annotation is also captured, including the reference, the
type of assay, the protein origin, and the biological system in which the
experiment was performed.
2.2 Datamodel
Annotation statements (Table 3A) are triplets composed of (1) a sub-
ject that corresponds to the protein variation being annotated; (2) an
object that describes the function being tested; (3) a relation describ-
ing how the function of the protein is affected by themutation.
The subjects are protein variations described using the HGVS
nomenclature (den Dunnen, Dalgleish et al., 2016). The origin of the
variation, either germline, somatic, or generatedby site-directedmuta-
genesis, as well as its consequence on the protein (non-synonymous
codon, stop gained, frameshift variant, in-frame codon gain, and
in-frame codon loss), are captured. The positions of the variations
on the protein sequence refer to the respective neXtProt entries
(for example SCN1A corresponds to NX_P35498 and SCN9A-iso3 to
NX_Q15858-3 in https://www.nextprot.org/).
The objects represent either (1) molecular and biological pro-
cesses or localizations from the Gene Ontology (GO) vocabulary (The
Gene Ontology Consortium, 2015), (2) electrophysiological param-
eters described with the Ion Channel ElectroPhysiology Ontology
(ICEPO), a specific ontology developed in our group (Hinard et al.,
2016), (3) mammalian phenotypes from the Mammalian Phenotype
Ontology (Smith & Eppig, 2012), (4) proteins, represented by Gaudet
et al. 2017 to describe effects on protein–protein interactions, or
(5) protein property, such as protein abundance and stability, rep-
resented by an in-house developed protein property vocabulary
(ftp://ftp.nextprot.org/pub/current_release/controlled_vocabularies/
cv_protein_property.obo).
The relations (Table 3B) linking the subject and the object are
grouped into two main concepts: “no impact” and having “impact.”
The possible impacts of variations can be further specified using
“increases,” “decreases,” or “gains function”; “causes phenotype” for
mammalian phenotype terms and specific impacts of variations on
electrophysiological parameters can be described with relevant rela-
tions such as “depolarizes,”, ”hyperpolarizes,” “hastens,” “slows,” or
“impacts temperature-dependence of.”
For each annotation, detailed information about the experimen-
tal support of each statement is captured as evidence statements
(Table 3C). The annotation evidence is composed of (1) one or more
terms from the Evidence and Conclusion Ontology (Chibucos et al.,
2014), describing the experiment performed, such as basic biological
experiments or specific types of electrophysiological recordings; (2)
the protein origin, which represents the species from which the pro-
tein was obtained for the experiment described using the NCBI taxon-
omy (https://www.ncbi.nlm.nih.gov/taxonomy); (3) the biological sys-
tem in which the experiment was done, that may contain one or more
of these elements: the organism from theNCBI taxonomy, the tissue or
cell type, from the CALOHA human anatomy vocabulary (ftp://ftp.next
prot.org/pub/current_release/controlled_vocabularies/caloha.obo) or
the cell line from the Cellosaurus knowledge resource (http://
web.expasy.org/cellosaurus/); (4) a qualitative assessmentof the sever-
ity of the phenotype, either “Mild,” “Moderate,” or “Severe”; (5) a qual-
ity flag; each evidence is labeled as either Gold (high quality) or Silver
(goodquality), knowing that the "Silver" tag is usedwherequality of the
experiment is not optimal according to curator’s judgment; and (6) one
reference, usually identified using a PubMed ID.
2.3 Assessment criteria for phenotype severity and
data confidence
The criteria used to grade the severity of the phenotypic observations
are based on the fold-change of activity, response, and so on, in the
mutant compared with the wild-type control under the same condi-
tions. A phenotype is considered “Mild” when the change is around
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TABLE 3 Annotation elements: (A) basic triplet statement for “SCN5A-p.Ser2014*” variant, (B) relations, and (C) evidence for the triplet
“SCN5A-p.Ser2014* decreasesmacroscopic conductance”
A. ANNOTATION
Element CV/Ontology Example
Subject HGVS nomenclature SCN5A-p.Ser2014*
Relation cv_modification_effect.obo Decreases
Object BioObject/GO/ICEPO/ Protein Property/MGI phenotype Binding to SNT (BioObject) cardiac conduction (GO)
macroscopic conductance (ICEPO) protein abundance
(Protein Property)
B. RELATIONS
No impact No significant effect observed comparedwith the wild-type
• Does not cause phenotype No observable morphological, physiological, and behavioral characteristics in themutant comparedwith the
wild-type
Impacts Some significant effect observed comparedwith the wild-type
• Causes phenotype Some observable morphological, physiological, and behavioral characteristics in themutant comparedwith
the wild-type
• Increases Some significant increase observed in a quantifiablemeasure comparedwith the wild-type
• Decreases Some significant decrease observed in a quantifiablemeasure comparedwith the wild-type
• Gains function Mutant protein acquires a property absent from thewild-type (new substrate, new cellular localization, etc.)
• Depolarizes Some significant shift of the curve in the depolarizing direction comparedwith the wild-type
• Hyperpolarizes Some significant shift of the curve in the hyperpolarizing direction comparedwith the wild-type
• Hastens Some significant higher value in the transition speed comparedwith the wild-type
• Slows Some significant lower value in the transition speed comparedwith the wild-type
• Impacts
temperature-dependence of
Some significant impact dependent on the temperature comparedwith the wild-type
C. EVIDENCE
Element CV/Ontology Example
Evidence code(s) Evidence and conclusion ontology Whole-cell voltage clamp recording protocol/knockin evidence
used inmanual assertion/current density
Protein origin NCBI taxonomy Musmusculus (NCBITaxID10090)
Biological model species, cell type,
anatomy, cell line
NCBI taxonomyCALOHA anatomy
ontology Cellosaurus
Musmusculus (NCBITaxID10090) Heart muscle cell
(CALOHA:TS-0115)
Phenotype intensity Mild/moderate/severe Moderate
Evidence quality Gold/silver Gold
Reference Cross-reference to PubMed PUBMED24895455
10%–20% of the control. “Moderate” is assigned when the change is
between 20% and 80% of the control, whereas “Severe” is used to
describe changes exceeding 80% of the control.
Each evidence is also assigned a qualitative confidence score, Gold
or Silver. This is subjective to some extent and varies on a case-by-case
basis, but our guidelines for assigning Gold quality to an experiment
require either good statistical significance (P<= 0.01; for experiments
where appropriate) or substantial relevance of the experiment, includ-
ing appropriate controls. For example, a Silver tag may be assigned
when the data are qualitative and/or statistical evaluation is missing,
when errors are very large, when the data result from a low confidence
assay (for example, low replicate number; poorly defined experimental
systems, etc.), or when the experiment is carried out in a non-human
protein that is evolutionarily distant from the human protein.
2.4 Quality control
To ensure data integrity, the annotations undergo both automated
and manual checks. Automated checks ensure that the annotation is
complete, that is, it contains a subject, a relation, an object, a refer-
ence, at least one evidence code, and the species in which the experi-
mentwasdone. In the case of sequence variations, our software checks
that the original amino acid at the position annotated is found in
the sequence being annotated. Also, manual checks are performed to
provide correct and consistent annotations. For example, controlled
vocabulary terms used in the annotations are checked to ensure that
terms used for biological processes were consistent throughout the
annotations corpus.Onceall the checks are successful, the annotations
obtain a “Valid” status and are integrated into the portal.
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F IGURE 2 Screenshot of the Ion Channels Variants Portal. Each column can be filtered for specific values and sorted alphabetically or numeri-
cally, depending on the data type. The number of entries corresponding to a search result appears above the table
TABLE 4 Number of variants and annotations in the Ion Channels Variants Portal per channel and number of disease-associated variants
obtained from theClinVar and neXtProt databases. The last rowpresents the proportion of naturally occurring variants fromour set of variants for
each channel
SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCN11A Total
Number of observations 535 860 51 1,294 1,063 163 514 119 59 4,658
Number of variants 51 184 7 200 112 27 59 27 5 672
Number of disease-associated variants 506 50 6 72 529 26 62 27 11 1,289
Proportion of natural variants 96% 12% 86% 20% 82% 22% 75% 27% 100%
3 RESULTS AND DISCUSSION
3.1 Creation of the Ion Channels Variant Portal
The Ion Channels Variants Portal is specific to voltage-gated sodium
channel gene family (SCN). It contains all pertinent knowledge
concerning mutations in the nine human voltage-sensitive sodium
channel proteins and their impact on the biophysical properties and
the biological processes of the channels. The portal provides an intu-
itive tool for rapidly searching and comparing the functional infor-
mation on Nav variants. All this information is publicly available at
https://www.nextprot.org/portals/navmut. The data are presented in
table format, as shown in Figure 2. The data are ordered alphabetically
by gene name and then by variant position. In addition, each column
can be filtered for specific values and the selected data can be down-
loaded in comma-separated or PDF format for a deeper analysis. The
content of each column is described in the portal documentation (“See
documentation” link).
3.2 Impact of Nav variants on protein function
The Ion Channels Variants Portal contains 4,658 phenotypic observa-
tions on 672 variants, both natural and artificially generated with at
least one phenotypic impact, extracted from264publications (Table 4).
The corpus of data available for each Nav varies widely, with SCN2A,
SCN4A, and SCN5A having the highest number of variants, whereas
SCN3A and SCN11A have the fewest number of variants. SCN1A,
SCN8A, SCN9A, and SCN10A have nearly identical number of variants
and an intermediate number of annotations compared with the oth-
ers. Most of the molecular and cellular assays done on the sodium
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F IGURE 3 Distribution of the variants according to the topological domains:A: DI–DIV domains versus cytoplasmic regions. Distribution of the
variants with electrophysiological defects: the natural variants (Nat_Var) versus artificial variants (Artif_Var) according to (B) the domains or to (C)
the segments
channels target electrophysiological parameters: about 80% of the
assays reported in the literature are relevant to channel electrophys-
iological functions, whereas only 20% of the experiments test the sub-
cellular localization, interactions, stability, and so on of the channels.
3.3 Distribution of Nav variants in different
topological regions, domains, and segments
To simplify the presentation of the variants distribution, we first
divided the proteins based on two topological types: the cytoplasmic
regions composed of the amino- and carboxyl-termini as well as the
three linkers L1, L2, andL3, and theDI–DIVdomains (mostly composed
of transmembrane regions).
Consistent with the important role of the DI–DIV domains in chan-
nel gating (Bennett et al., 1995), most variants are located in these
regions (Figure 3A): seven out the nine channels have over 60% of
their variants in the DI–DIV domains. However, the SCN5A and SCN8A
variants are evenly distributed between the domains and cytoplas-
mic regions. In the case of SCN5A, the cytoplasmic regions have been
extensively studied because they are targeted by a high proportion of
disease-causing mutations. The underlying defect of the SCN5Amuta-
tions in the L3 and the C-terminal regions has been linked to their role
in the inactivation gating process (Bennett et al., 1995; Mantegazza,
Yu, Catterall, & Scheuer, 2001;Wehrens et al., 2003). It is not clearwhy
SCN8A has a smaller fraction ofmutations in theDI–DIV domains com-
paredwith other Navs; it may be a bias due to the relatively small num-
ber of variants analyzed.
Another interesting point is to see whether there is a difference
in the localization of the variants with respect to their origin (natural
versus artificial). From the 672 characterized variants, 272 are natural
and 400 are artificial (40% and 60%, respectively). Analysis of their
distribution reveals that there are a majority of artificially generated
variants in the DI–DIV domains (Table 5). While the artificial variants
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TABLE 5 Number of natural (Nat_var) or artificial variants (Artif_var) present in DI–DIV domains or cytoplasmic regions (cyto)
SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A SCN11A Total
Nat_var in DI–DIV domains 43 17 6 30 47 5 33 5 5 191
Nat_var in cyto regions 6 6 0 10 45 1 11 2 0 81
Artif_var in DI–DIV domains 2 137 0 130 7 8 8 12 0 304
Artif_var in cyto regions 0 24 1 30 13 13 7 8 0 96
Total of variants 51 184 7 200 112 27 59 27 5 672
are generated primarily to understand channel function, with an
emphasis on the important DI–DIV domains, the same regions are
targeted by disease-associated variants. Therefore, the inclusion of
artificially generated variants in the annotation corpus does not bias
the data analysis but on the contrary contributes to the understanding
of variation impacts.
3.4 Distribution of electrophysiological phenotypes
3.4.1 Distribution of variants within DI–DIV domains
SCN proteins are composed of four domains (DI–DIV; Figure 1), each
made up of six membrane spanning helical segments (S1–S6). The four
domains of Nav channels form the central ion conducting pore and the
voltage-sensor domain (VSD) of the protein. The DI–DIII domains are
essentially involved in activation, whereas the DIV plays a specific role
in fast inactivation (Ahern et al., 2016; Goldschen-Ohm, Capes, Oel-
strom, & Chanda, 2013). Variations impacting the electrophysiological
parameters are mostly found in these four domains. The proportion of
natural and artificial variants are roughly similar for all regions, except
for domains DIII and DIV that contain more artificial mutants due to
their extensive study in SCN2A and SCN4A (Figure 3B).
3.4.2 Distribution of variants within S1–S6
transmembrane segments
Looking in more detail at the S segments regardless of the domain
they belong to, we observed that the natural variants impacting elec-
trophysiological parameters are distributed predominantly in the S4
segment (41%), whereas the artificial variants are mainly localized in
the S6 segment (37%) (Figure 3C). The S6 segments are critical for
permeation and fast inactivation because of their close proximity with
the selectivity filter and inactivation gate (McPhee, Ragsdale, Scheuer,
& Catterall, 1994, 1995), whereas the S4 segments play an essential
role in VSD (Stuhmer et al., 1989). In addition, the S4 segments of
the DIV domain have been shown to play a unique role in activation–
inactivation coupling (Chen, Santarelli, Horn, &Kallen, 1996). Interest-
ingly, a large fraction of disease-causing variants are also localized in
these segments: 25% in S4 and 23% in S6. Thus as expected, the elec-
trophysiological variant distribution correlates with the importance of
the D domains and the S segments on the channel function.
3.5 Distribution of non-electrophysiological
phenotypes
Finally, we looked at the annotations affecting phenotypes other than
electrophysiological parameters such as the binding, signaling, effect
on cellular function, localization, and degradation. We noticed that
these variants are mostly localized in the cytoplasmic regions (N-
terminus, linkers, and C-terminus) rather than in the domains DI–DIV
(63% and 37%, respectively) that is most likely related to the fact that
transmembrane sequences from the domains offer less physical access
to binding. All these variants impair interactions with intracellular
proteins (outlined in Table 2) that regulate the trafficking and/or
activity of the channels, including protein kinases (PKC, PKA,
CSNK2A2, GSK3B, etc.), ubiquitin-protein ligases (NEDD4 and
NEDD4L), and trafficking partners such as Ankyrin (ANK2 and ANK3),
Syntrophin (SNTA1, SNTB1, SNTB2, SNTG1, SNTG2), fibroblast growth
factor homologous factors 1–4 (FGF-11/-12/-13/-14) calmodulin, and
so on (Abriel & Kass, 2005).
3.6 Comparison of disease-associated variants and
experimentally characterized variants
One important challenge in medicine is to correlate the symptoms
of patients (phenotypes) with the causative genetic variations. Con-
versely, as genome sequencing is expected to become a standardmed-
ical laboratory practice, it may be possible to identify mutations in
individuals before any symptoms are visible. This practice may be
especially relevant for Nav variants, as several associated diseases
have a relatively late onset and mild disease progression, thus provid-
ing ample opportunities for disease prevention or attenuation if diag-
nosed in time. Our portal has therefore important potential applica-
tions in this area. A total of 1,289 disease-associated variants in the
nine voltage-gated sodium channels were obtained from ClinVar and
neXtProt (Table 4), 18% of which the portal has functional annota-
tions (231 variants). Hence, the largest fraction of disease-associated
variants is not characterized. Nevertheless, there are 441 variants
not described to cause diseases but with functional data that could
contribute to understand the pathogenic potential of new or paral-
ogous variants. A detailed view of the overlap in the disease vari-
ants and the variants characterized experimentally is shown in Fig-
ure 4 where the fraction of variants in each of the domains and link-
ers is shown for each Nav. The overall distribution of the variants
with phenotypic data generally matches that of the disease variants,
except for the C-terminal region. This exception is likely due to the
specific research focus on the regulatory interactions occurring in this
region, for example with calmodulin and NEDD4L. These data indicate
that despite the importance of this C-terminal region, only few nat-
ural mutations have been found in this region and shown to trigger
disorders.
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F IGURE 4 Stacked fraction of (A) the disease-causing variants per region and of (B) the characterized variants per region
4 CONCLUSIONS
The Ion Channels Variants Portal we have developed provides an
exhaustive list of variants in voltage-gated sodium ion channels for
which molecular phenotypes are available, curated in a highly struc-
turedmodel,with detailed information about the experimental system,
without redundancy in the data and with complete traceability to the
original experimental results. Researchers aswell as clinical geneticists
will be able to consult this database to have a comprehensive overview
of the available data, which may be used to support the clinical deci-
sion process. Furthermore, with the large amount of data available,
correlations between different mutations and certain diseases may
be used to predict the effect of similar mutations in paralogous
proteins.
The Ion Channels Variants Portal will undoubtedly be a useful
resource for a better understanding of ion channel function, essential
for understanding channelopathies. To be consistent with this aim, we
will continue our effort to integrate newly characterized Nav variants
and we welcome contact with groups having data sets that they would
like to be considered for inclusion in the portal. Finally, we also plan to
use the same approach to expand the annotation corpus to other ion
channels.
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